Drug shortages homepage

Welcome to Drug Shortages Canada, the website for reporting drug shortages and discontinuations in Canada. The Food and Drug Regulations require drug sellers to report when they are not able to meet demand for a product or when they stop selling a product. Information about the website and the regulations can be found on the About & Resources Page.

A shortage means, in respect of a drug, a situation in which the manufacturer to whom a document was issued under subsection C.01.014.2(1) that sets out the drug identification number assigned for the drug is unable to meet the demand for the drug.

Below are the newest and most recently updated Shortage and Discontinuation reports.

Drug pills

Shortage Reports

Brand name Company Name Status Strength Update Date Updated View Report
OMNIPAQUE 240 GE HEALTHCARE CANADA INC Actual shortage 518MG New Report 2019-06-19 87081
APO-SELEGILINE APOTEX INC Actual shortage 5MG New Report 2019-06-19 87064
CANDESARTAN SANIS HEALTH INC Anticipated shortage 4MG New Report 2019-06-19 87077
JALYN GLAXOSMITHKLINE INC Anticipated shortage 0.4MG 0.5MG Updated Report 2019-06-19 84337
CLINDOXYL GEL GLAXOSMITHKLINE INC Actual shortage 50MG 10MG Updated Report 2019-06-19 85790
ROPINIROLE SANIS HEALTH INC Anticipated shortage 0.25MG New Report 2019-06-19 87069
TELMISARTAN SANIS HEALTH INC Actual shortage 40MG Updated Report 2019-06-19 86050
ATOMOXETINE SANIS HEALTH INC Actual shortage 10MG Updated Report 2019-06-19 76872
APO-QUINAPRIL/HCTZ APOTEX INC Actual shortage 12.5MG 20MG New Report 2019-06-19 87060
APO-AMOXI CLAV APOTEX INC Actual shortage 875MG 125MG New Report 2019-06-19 87057

Discontinuation Reports

Brand name Company Name Status Strength Update Date Updated View Report
APO-GEMFIBROZIL CAP 300MG USP APOTEX INC Discontinued New Report 2019-06-12 86557
APO-EXEMESTANE APOTEX INC Discontinued New Report 2019-06-12 86552
APO-CIPROFLOX APOTEX INC Discontinued New Report 2019-06-12 86547
APO-CEFPROZIL APOTEX INC Discontinued New Report 2019-06-12 86542
APO-TOLTERODINE APOTEX INC Discontinued 2MG Updated Report 2019-06-12 60828
APO-RISPERIDONE APOTEX INC Discontinued 3.0MG Updated Report 2019-06-12 60750
APO OXAZEPAM TAB 30MG APOTEX INC Discontinued 30MG Updated Report 2019-06-12 60681
APO-METFORMIN 850 MG TABLETS APOTEX INC Discontinued 850MG Updated Report 2019-06-12 40778
APO-BROMAZEPAM - TAB 3MG APOTEX INC Discontinued 3MG Updated Report 2019-06-12 60307
APO-CAPTO TAB 6.25MG APOTEX INC Discontinued 6.25MG Updated Report 2019-06-12 60339
TRAMADOL / ACETAMINOPHEN SIVEM PHARMACEUTICALS ULC To be discontinued 37.5MG 325MG New Report 2019-06-12 86439
BICALUTAMIDE SIVEM PHARMACEUTICALS ULC To be discontinued 50MG New Report 2019-06-12 86436
BICALUTAMIDE SIVEM PHARMACEUTICALS ULC To be discontinued 50MG New Report 2019-06-12 86431
GONAL-F EMD SERONO A DIVISION OF EMD INC CANADA To be discontinued 77MCG Updated Report 2019-06-12 75742
GONAL-F EMD SERONO A DIVISION OF EMD INC CANADA To be discontinued 33MCG Updated Report 2019-06-12 75734
DIPROLENE MERCK CANADA INC To be discontinued 0.5MG Updated Report 2019-06-11 68027
HYCAMTIN NOVARTIS PHARMACEUTICALS CANADA INC Discontinued 4MG Updated Report 2019-06-11 8129
MYOCHRYSINE SANOFI-AVENTIS CANADA INC Discontinued 50MG New Report 2019-06-10 86073
MYOCHRYSINE SANOFI-AVENTIS CANADA INC Discontinued 25MG New Report 2019-06-10 86070
MYOCHRYSINE SANOFI-AVENTIS CANADA INC Discontinued 10MG New Report 2019-06-10 86067